These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 17545513

  • 1. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X.
    Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X, Egami H, Nozawa F, Abe M, Baba H.
    Int J Oncol; 2006 Feb 01; 28(2):369-74. PubMed ID: 16391791
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z, Guo H, Wai PY, Gao C, Kuo PC.
    Carcinogenesis; 2006 Jun 20; 27(6):1134-45. PubMed ID: 16474180
    [Abstract] [Full Text] [Related]

  • 6. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 7. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y.
    Gynecol Oncol; 2009 Aug 01; 114(2):265-72. PubMed ID: 19450871
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.
    Maupas-Schwalm F, Bedel A, Augé N, Grazide MH, Mucher E, Thiers JC, Salvayre R, Nègre-Salvayre A.
    Cell Signal; 2009 Dec 01; 21(12):1925-34. PubMed ID: 19735728
    [Abstract] [Full Text] [Related]

  • 10. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 01; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 11. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T, Behrendt N, Ploug M.
    Stem Cells; 1997 Jan 01; 15(6):398-408. PubMed ID: 9402652
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
    Harvey SR, Hurd TC, Markus G, Martinick MI, Penetrante RM, Tan D, Venkataraman P, DeSouza N, Sait SN, Driscoll DL, Gibbs JF.
    Clin Cancer Res; 2003 Oct 15; 9(13):4935-43. PubMed ID: 14581368
    [Abstract] [Full Text] [Related]

  • 13. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct 15; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 14. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T, Kakkar AK, Tuddenham EG, Williamson RC, Lemoine NR.
    Cancer Res; 1998 Oct 01; 58(19):4461-7. PubMed ID: 9766679
    [Abstract] [Full Text] [Related]

  • 15. Expression and activation of proteases in co-cultures.
    Paduch R, Kandefer-Szerszeń M.
    Exp Toxicol Pathol; 2011 Jan 01; 63(1-2):79-87. PubMed ID: 19836935
    [Abstract] [Full Text] [Related]

  • 16. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 01; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 17. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Cancer Res; 2003 May 15; 63(10):2454-61. PubMed ID: 12750266
    [Abstract] [Full Text] [Related]

  • 18. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep 15; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 19. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 15; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 20. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Apr 15; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.